CorePharma

Founded in 1998, CorePharma is a "Quality Driven + People Powered" U.S. based Oral Solid Dosage CDMO with a strong compliance track record. Our focus is on providing our clients with a platform for success. We provide comprehensive end-to-end solution, from development through to commercial launch, back by our industry-leading customer service. Our state-of-the-art development, analytical, manufacturing and packaging facilities uphold the highest quality standards, with a total annual capacity of 5 billion dosage units - covering development, pilot scale and commercial operations. CorePharma continuously invests in cutting-edge technologies and capabilities, ensuring we are the one-stop shop for all your CDMO needs.

Type of Drugs Manufactured:

Small Molecule

CDMO Services:

Research & Development;Packaging;Regulatory Services;Analytical Development

No. of Manufacturing Facilities:

3-5

Facilities Locations:

North America

Regulatory Approvals for facilities:

FDA (United States);ISO;GMP

Manufacturing Technologies:

Liquids;Solids

Company Products and Services:

CMO/CDMO

Current Capacity:

Our facilities currently have available capacity and are ready to take on new client projects. We are well-equipped to handle additional development and manufacturing needs and would be happy to discuss how we can support new business.